Raising The Bar On The Biologics Potential - a podcast by Drug Discovery World (DDW)

There is continued pressure to fill the drug pipeline and, at the same time, globalisation of personalised medicines is complex, expensive and requires a significant time commitment.

Risk, perception and regulation have limited the adoption of biologics, biosimilars and biobetters, as small molecules and synthetic drugs have been the traditional therapeutic standard. Fortunately, innovative biological therapeutic tools and technologies are now proven to be viable, highly effective, low risk and safe.

Further episodes of The Drug Discovery World Podcast

Further podcasts by Drug Discovery World (DDW)

Website of Drug Discovery World (DDW)